期刊
NEURAL REGENERATION RESEARCH
卷 18, 期 2, 页码 404-409出版社
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/1673-5374.346466
关键词
brain-derived neurotrophic factor; exosome; inflammation; ischemic stroke; neural stem cell; neurogenesis; neurological recovery; transplantation
In this study, we engineered exosomes (BDNF-hNSC-Exo) by loading brain-derived neurotrophic factor (BDNF) into exosomes derived from neural stem cells (NSCs). These engineered exosomes showed enhanced cell survival and promoted neuronal differentiation, suggesting their potential therapeutic role in ischemic stroke.
Our previous study demonstrated the potential therapeutic role of human neural stem cell-derived exosomes (hNSC-Exo) in ischemic stroke. Here, we loaded brain-derived neurotrophic factor (BDNF) into exosomes derived from NSCs to construct engineered exosomes (BDNF-hNSC-Exo) and compared their effects with those of hNSC-Exo on ischemic stroke both in vitro and in vivo. In a model of H2O2-induced oxidative stress in NSCs, BDNF-hNSC-Exo markedly enhanced cell survival. In a rat middle cerebral artery occlusion model, BDNF-hNSC-Exo not only inhibited the activation of microglia, but also promoted the differentiation of endogenous NSCs into neurons. These results suggest that BDNF can improve the function of NSC-derived exosomes in the treatment of ischemic stroke. Our research may support the clinical use of other neurotrophic factors for central nervous system diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据